These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16980758)

  • 1. [Change of concentration of L-carnitine in blood and other tissues in rats on a background of the alcohol intake and influence of mildronate on its level].
    Sakvarelidze EP
    Georgian Med News; 2006 Aug; (137):94-6. PubMed ID: 16980758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Change of concentration endothelin-1 in rats on a background of alcohol and /or mildronate treatment].
    Sakvarelidze EP; Zakaraia MV; Megreladze TI
    Georgian Med News; 2006 Jun; (135):131-4. PubMed ID: 16905832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term mildronate treatment on cardiac and liver functions in rats.
    Liepinsh E; Kuka J; Svalbe B; Vilskersts R; Skapare E; Cirule H; Pugovics O; Kalvinsh I; Dambrova M
    Basic Clin Pharmacol Toxicol; 2009 Dec; 105(6):387-94. PubMed ID: 19663820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine.
    Kuka J; Vilskersts R; Cirule H; Makrecka M; Pugovics O; Kalvinsh I; Dambrova M; Liepinsh E
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):215-22. PubMed ID: 21903968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine depletion in rat pups from mothers given mildronate: a model of carnitine deficiency in late fetal and neonatal life.
    Peschechera A; Scalibastri M; Russo F; Giarrizzo MG; Carminati P; Giannessi F; Arduini A; Ricciolini R
    Life Sci; 2005 Oct; 77(24):3078-91. PubMed ID: 15979102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR-/- mice.
    Vilskersts R; Liepinsh E; Mateuszuk L; Grinberga S; Kalvinsh I; Chlopicki S; Dambrova M
    Pharmacology; 2009; 83(5):287-93. PubMed ID: 19325254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.
    Liepinsh E; Vilskersts R; Loca D; Kirjanova O; Pugovichs O; Kalvinsh I; Dambrova M
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):314-9. PubMed ID: 17204911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the effect of an inhibitor of carnitine-dependent metabolism of mildronate on the oxidation of fatty acids in the liver mitochondria of intact rats].
    Kagan TI; Simkhovich BZ; Kalvinysh IIa; Lukevits EIa
    Vopr Med Khim; 1991; 37(2):44-6. PubMed ID: 1897193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of the carnitine biosynthesis inhibitor mildronate on the lipid metabolic indices of rats].
    Shutenko ZhV; Priedena IA; Mezhapuke RIa; Simkhovich BZ; Kalvin'sh IIa; Lukevits EIa
    Farmakol Toksikol; 1991; 54(2):55-6. PubMed ID: 1884799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mildronate treatment alters γ-butyrobetaine and l-carnitine concentrations in healthy volunteers.
    Liepinsh E; Konrade I; Skapare E; Pugovics O; Grinberga S; Kuka J; Kalvinsh I; Dambrova M
    J Pharm Pharmacol; 2011 Sep; 63(9):1195-201. PubMed ID: 21827492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mildronate: cardioprotective action through carnitine-lowering effect.
    Dambrova M; Liepinsh E; Kalvinsh I
    Trends Cardiovasc Med; 2002 Aug; 12(6):275-9. PubMed ID: 12242052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats.
    Liepinsh E; Vilskersts R; Zvejniece L; Svalbe B; Skapare E; Kuka J; Cirule H; Grinberga S; Kalvinsh I; Dambrova M
    Br J Pharmacol; 2009 Aug; 157(8):1549-56. PubMed ID: 19594753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of mildronate on carnitine-dependent and carnitine-independent ketogenesis in rats].
    Simkhovich BZ; Meĭrena DV; Khagi KhB; Shutenko ZhV; Molodchina TN; Kalvin'sh IIa; Lukevits EIa
    Farmakol Toksikol; 1991; 54(4):41-2. PubMed ID: 1786824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mildronate, the inhibitor of L-carnitine transport, induces brain mitochondrial uncoupling and protects against anoxia-reoxygenation.
    Makrecka M; Svalbe B; Volska K; Sevostjanovs E; Liepins J; Grinberga S; Pugovics O; Liepinsh E; Dambrova M
    Eur J Pharmacol; 2014 Jan; 723():55-61. PubMed ID: 24333219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of L-carnitine and mildronate improves endothelial function and decreases mortality in hypertensive Dahl rats.
    Vilskersts R; Kuka J; Svalbe B; Cirule H; Liepinsh E; Grinberga S; Kalvinsh I; Dambrova M
    Pharmacol Rep; 2011; 63(3):752-62. PubMed ID: 21857086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of l-carnitine and mildronate on the mitochondrial metabolism of heart and bacterial composition of the gut microbiome in ageing mice.
    Volodina DE; Gureev AP; Shaforostova EA; Gryaznova MV; Ignatyeva DA; Popov VN
    Life Sci; 2022 Mar; 293():120333. PubMed ID: 35051422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fatty acid analogue targeting mitochondria exerts a plasma triacylglycerol lowering effect in rats with impaired carnitine biosynthesis.
    Lindquist C; Bjørndal B; Rossmann CR; Svardal A; Hallström S; Berge RK
    PLoS One; 2018; 13(3):e0194978. PubMed ID: 29590220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of a structural analog of gamma-butyrobetaine, mildronate, [3-2,2,2-trimethylhydrazine)propionate] on dynamic carnitine-dependent metabolism].
    Shutenko ZhV; Priedena IA; Kalvin'sh IIa; Lukevits EIa
    Vopr Med Khim; 1991; 37(3):24-6. PubMed ID: 1949676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart.
    Liepinsh E; Vilskersts R; Skapare E; Svalbe B; Kuka J; Cirule H; Pugovics O; Kalvinsh I; Dambrova M
    Life Sci; 2008 Oct; 83(17-18):613-9. PubMed ID: 18801379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-atherosclerotic action of mildronate in experiment].
    Okunevich IV; Ryzhenkov VE
    Patol Fiziol Eksp Ter; 2002; (2):24-7. PubMed ID: 12152427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.